Head-to-head
NovoCare Pharmacy (Wegovy) vs bmiMD
Compared on semaglutide across the eight dimensions this database records. They differ on 6 of those eight. bmiMD is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
NovoCare Pharmacy (Wegovy) is $349 a month all-in for semaglutide; bmiMD is $129. Over twelve months that is $4,188 against $1,188. Value Scores are 45.9 and 95.5 out of 100.
Semaglutide
Plan pages: NovoCare Pharmacy (Wegovy) plans · bmiMD plans
At 2.4 mg/week, NovoCare Pharmacy (Wegovy) is $349 a month all-in and bmiMD is $129 — $220 apart, or $2,640 across a year. Over twelve months the totals are $4,188 (billed monthly) and $1,188 (prepaid term).
NovoCare Pharmacy (Wegovy) charges a flat $349 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
bmiMD charges a flat $129 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | NovoCare Pharmacy (Wegovy) | Rank | bmiMD | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $349 | 31/32 | $129 | 2/32 | bmiMD by $220 |
| 0.5 mg | $349 | 21/21 | $129 | 1/21 | bmiMD by $220 |
| 1 mg | $349 | 21/21 | $129 | 1/21 | bmiMD by $220 |
| 1.7 mg | $349 | 21/21 | $129 | 1/21 | bmiMD by $220 |
| 2.4 mg | $349 | 27/29 | $129 | 1/29 | bmiMD by $220 |
bmiMD is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, NovoCare Pharmacy (Wegovy) sits 26 of 29 on all-in monthly cost and bmiMD sits 1. There are 24 other programs priced between them. The field median is $249 and the floor is $129, so bmiMD is below the median and the other is above it. NovoCare Pharmacy (Wegovy) is $220 above the cheapest semaglutide program on record. bmiMD is the cheapest semaglutide program on record at this basis.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — NovoCare Pharmacy (Wegovy) undercuts it by $0, bmiMD by $220. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | NovoCare Pharmacy (Wegovy) | bmiMD | Cheaper |
|---|---|---|---|
| Month to month | $349 | $129 | bmiMD by $220 |
| 3-month term | — | $119 | only bmiMD publishes this term |
| 6-month term | — | $109 | only bmiMD publishes this term |
| 12-month term | — | $99 | only bmiMD publishes this term |
| Settled dose | NovoCare Pharmacy (Wegovy) | bmiMD | Difference |
|---|---|---|---|
| 0.25 mg | $4,188 | $1,548 | $2,640 apart |
| 0.5 mg | $4,188 | $1,548 | $2,640 apart |
| 1 mg | $4,188 | $1,548 | $2,640 apart |
| 1.7 mg | $4,188 | $1,548 | $2,640 apart |
| 2.4 mg | $4,188 | $1,548 | $2,640 apart |
NovoCare Pharmacy (Wegovy) publishes no rate for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $4,188 on NovoCare Pharmacy (Wegovy) and $1,548 on bmiMD. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
Value Scores are 45.9 for NovoCare Pharmacy (Wegovy) and 95.5 for bmiMD, against a semaglutide category floor of $129. bmiMD leads by 49.6 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| NovoCare Pharmacy (Wegovy) | 25.9 | 15.0 | 0 | 5 | 45.9 |
| bmiMD | 70.0 | 10.5 | 10 | 5 | 95.5 |
Where the two programs differ
All-in monthly
bmiMD is cheaper month to month — $129 against $349, a gap of $220 every month, or $2,640 across a year if both rates hold.
Cancellation terms
Cancellation differs: NovoCare Pharmacy (Wegovy) states No subscription lock, while bmiMD states Per provider terms; confirm cancellation policy at enrollment. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
NovoCare Pharmacy (Wegovy) asks for None; bmiMD asks for Monthly, 3-month, 6-month, or 12-month plans; price varies by term, not by dose. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
bmiMD charges one price at every dose; NovoCare Pharmacy (Wegovy) prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. NovoCare Pharmacy (Wegovy)'s figure is verified and bmiMD's is reported. NovoCare Pharmacy (Wegovy) rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $4,188 for NovoCare Pharmacy (Wegovy) and $1,188 for bmiMD. bmiMD is lower by $3,000 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
NovoCare Pharmacy (Wegovy) Official site
Novo Nordisk's direct cash pharmacy sells FDA-approved Wegovy pens at $349/month across standard doses ($399 for the 7.2 mg HD pen), with a $199 introductory price on the first two starter-dose fills and oral Wegovy tablets from $149/month. It is the FDA-approved semaglutide price floor and the benchmark for every compounded semaglutide quote.
It names its compounding pharmacy — CoAssist Pharmacy d/b/a NovoCare Pharmacy, recorded as Manufacturer direct — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None; cancellation is No subscription lock; availability is stated as 50 states.
Evidence: verified — captured at checkout by our desk on the stated date, captured . Source — novocare.com price guide and savings-offer pages, retrieved 2026-08-11
Watch: The $199 intro and the $149 oral tier both carry published expiration dates; the durable numbers are $349 pen / $399 HD.
bmiMD Official site
bmiMD is a compounded GLP-1 telehealth platform notable for flat per-dose pricing — the rate stays the same whether you're at 2.5 mg or 15 mg — and one of the widest plan-tier menus in the market. Its $99/mo semaglutide and $139/mo tirzepatide on the twelve-month plan are the lowest annualized figures in the dataset for both molecules.
It does not publicly name its compounding pharmacy; the record shows Named 503A pharmacy partner (specific pharmacy not publicly identified on pricing page), so who actually makes the medication cannot be independently verified; commitment terms are Monthly, 3-month, 6-month, or 12-month plans; price varies by term, not by dose; cancellation is Per provider terms; confirm cancellation policy at enrollment; availability is stated as Availability at enrollment; confirm your state at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com cheapest-compounded-tirzepatide-online, capture verified 2026-07-14
Watch: bmiMD's 12-month semaglutide plan at $99/mo is the lowest annualized sema figure in our dataset, beating NexLife's $119/mo and Oak's $133 m2m. Month-to-month sema at $129 also beats Oak's $133, making bmiMD the new m2m sema leader. Tirzepatide 12-month at $139 ties NexLife. Figures are reported status from RangeYourself's July 2026 first-party captures; our independent checkout is pending.
Which molecules each one carries
NovoCare Pharmacy (Wegovy) carries semaglutide at $349 a month; does not offer tirzepatide.
bmiMD carries tirzepatide at $179 a month and semaglutide at $129 a month.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
NovoCare Pharmacy (Wegovy) does not publish
- no published twelve-month semaglutide rate
bmiMD does not publish
- no named compounding pharmacy
- no state-by-state availability list — it says Availability at enrollment; confirm your state at intake
- no specific cancellation or refund terms
Ask NovoCare Pharmacy (Wegovy) and bmiMD for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. bmiMD carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. bmiMD publishes a twelve-month rate of $99 a month against $129 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, bmiMD Official site wins this matchup. If you expect to titrate to the top of the ladder, bmimd's flat pricing is worth more than the headline gap suggests; and if you would rather trust a better-evidenced number, novocare pharmacy (wegovy)'s price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. NovoCare Pharmacy (Wegovy)'s semaglutide price is verified as of 2026-08-11; bmiMD's is reported as of 2026-07-14.
Questions
Is NovoCare Pharmacy (Wegovy) or bmiMD cheaper for semaglutide?
bmiMD is cheaper on all-in monthly cost at 2.4 mg/week: $129 against $349, a difference of $220 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of NovoCare Pharmacy (Wegovy) versus bmiMD?
NovoCare Pharmacy (Wegovy) works out to $4,188 across twelve months and bmiMD to $1,188, on the plan terms each publishes.
Does NovoCare Pharmacy (Wegovy) or bmiMD raise the price as the dose goes up?
NovoCare Pharmacy (Wegovy): yes, it prices by dose. bmiMD: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do NovoCare Pharmacy (Wegovy) and bmiMD differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of NovoCare Pharmacy (Wegovy) and bmiMD names its pharmacy?
NovoCare Pharmacy (Wegovy) does — CoAssist Pharmacy d/b/a NovoCare Pharmacy. bmiMD does not, recording only Named 503A pharmacy partner (specific pharmacy not publicly identified on pricing page), so who makes its medication cannot be independently verified.
How well evidenced are the NovoCare Pharmacy (Wegovy) and bmiMD prices?
NovoCare Pharmacy (Wegovy)'s semaglutide figure is verified — captured at checkout by our desk on the stated date — captured 2026-08-11. bmiMD's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: NovoCare Pharmacy (Wegovy) official site · bmiMD official site. Compounded tirzepatide and semaglutide are not FDA-approved products.